Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 153 participants.
Also called NCT07122167
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 153 participants
- Sponsor
- MDCECRO LLC
- Registry
-
NCT07122167
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Recruiting
Technical summary
Registry record NCT07122167. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-02 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- Peripheral Drug-eluting Stent System
- Lead sponsor
- MDCECRO LLC
- Collaborator
- Zylox-Tonbridge Medical Technology Co., Ltd.
Record details
- Record id
cardio:ct-nct07122167- Content hash
a1581360d5604c6d127bb6ecb5ad85f28e2810863f38f296440643a84c4dfcde